Horiba for Healthcare

Appeler Itinéraire Site Web

Horiba for Healthcare Proven quality and trustworthy performance have established widespread confidence in the HORIBA brand.

HORIBA provides an extensive and comprehensive line of hematology, hemostasis, and clinical chemistry solutions (including analyzers, reagents, and consumables) for use in in vitro diagnostics. Today, more than 30,000 laboratories are using HORIBA’s healthcare solutions around the world.

World Thrombosis Day 2026 highlights the importance of women's health across the lifespan and the need for greater aware...
13/10/2026

World Thrombosis Day 2026 highlights the importance of women's health across the lifespan and the need for greater awareness of thrombosis risk.
Among the conditions that deserve attention is Antiphospholipid Syndrome (APS), an autoimmune disorder associated with thrombosis and adverse pregnancy outcomes. Accurate laboratory investigation, including lupus anticoagulant testing, plays a key role in supporting diagnosis and patient management.
🔗In our latest article, discover why quality starts before the analysis and explore key considerations for confident APS assessment: https://eu1.hubs.ly/H0y_QdQ0

Veterinary hematology is where the workflow begins.​​The Yumivet VH2500 supports veterinary laboratories with fast, deta...
09/10/2026

Veterinary hematology is where the workflow begins.​​
The Yumivet VH2500 supports veterinary laboratories with fast, detailed hematology results and a workflow designed for demanding daily activity.​
​
Designed for multi-species hematology testing, the Yumivet VH2500 combines a throughput of up to 120 samples per hour, continuous sample loading, STAT access, and 57 reportable parameters to deliver fast and reliable hematology insights for veterinary laboratories.​
​
👉 Explore Yumivet VH2500 and contact our team: https://eu1.hubs.ly/H0yYRsp0

Complete Blood Count (CBC) remains one of the most frequently ordered laboratory tests, yet valuable inflammatory biomar...
08/10/2026

Complete Blood Count (CBC) remains one of the most frequently ordered laboratory tests, yet valuable inflammatory biomarkers such as the Neutrophil-to-Lymphocyte Ratio (NLR) and Granulocyte-to-Lymphocyte Ratio (GLR) are often underutilized.

This workshop will explore the biological significance of these hematological ratios and how, when combined with C-reactive Protein (CRP), they can provide additional insights into immune response, inflammation, and disease severity.

Participants will discover how these biomarkers can support clinical decision-making, risk stratification, and the management of infectious and inflammatory conditions. The workshop will also examine the role of NLR, GLR, and CRP in disease severity assessment and explore how factors such as age and comorbidities can influence biomarker interpretation.

🔗Sign up here: https://eu1.hubs.ly/H0yZ8l20

Meet HORIBA at COLABIOCLI XXVII 2026 in Santa Cruz de la Sierra, Bolivia!Join us October 7-10 and visit our partner DIAM...
07/10/2026

Meet HORIBA at COLABIOCLI XXVII 2026 in Santa Cruz de la Sierra, Bolivia!
Join us October 7-10 and visit our partner DIAMEDIC at Booth #27 to discover the latest innovations in hematology and hemostasis, including the Yumizen H500 hematology analyzer and the Yumizen G405 hemostasis analyzer.

Don't miss our exclusive HORIBA workshops on October 9:
🔹 Coagulation Workshop: The Clinical Value and Biological Variability of D-Dimer Assays, Presented by Bruno Pougault, HORIBA ABX SAS
🔹 Hematology Workshop: Clinical Performance of Immature Leukocytes and Blasts from Extended Leukocyte Differential Counts and System Flags on HORIBA Yumizen H2500, Presented by Pascal Berthet, HORIBA ABX SAS

Whether you're a laboratory technician, laboratory manager, clinician, distributor, or interested in becoming a HORIBA distribution partner in Latin America, this is a great opportunity to connect with our team, explore our solutions, and discuss future collaborations.

We look forward to meeting you in Bolivia!

Congress registration: https://eu1.hubs.ly/H0yVLF40

06/10/2026

In this short video, Dr. Gulnaz Zhumagualieva, Head of the Laboratory at Sayram Central District Hospital, shares her experience after nearly six years of using the semi-automated hemostasis analyzer Yumizen G400 she introduced, and explains how evolving requirements are shaping future automation plans.
👉Discover the Yumizen hemostasis solutions here: https://eu1.hubs.ly/H0yS-DJ0

Meet HORIBA at COLABIOCLI XXVII 2026 in Santa Cruz de la Sierra, Bolivia!Join us October 7-10 and visit our partner DIAM...
02/10/2026

Meet HORIBA at COLABIOCLI XXVII 2026 in Santa Cruz de la Sierra, Bolivia!
Join us October 7-10 and visit our partner DIAMEDIC at Booth #27 to discover the latest innovations in hematology and hemostasis, including the Yumizen H500 hematology analyzer and the Yumizen G405 hemostasis analyzer.

Don't miss our exclusive HORIBA workshops on October 9:
🔹 Coagulation Workshop: The Clinical Value and Biological Variability of D-Dimer Assays, Presented by Bruno Pougault, HORIBA ABX SAS
🔹 Hematology Workshop: Clinical Performance of Immature Leukocytes and Blasts from Extended Leukocyte Differential Counts and System Flags on HORIBA Yumizen H2500, Presented by Pascal Berthet, HORIBA ABX SAS

Whether you're a laboratory technician, laboratory manager, clinician, distributor, or interested in becoming a HORIBA distribution partner in Latin America, this is a great opportunity to connect with our team, explore our solutions, and discuss future collaborations.

We look forward to meeting you in Bolivia!

Congress registration: https://eu1.hubs.ly/H0yrv7S0

When dengue NS1 antigen and antibody tests come back negative during the acute phase, clinicians face a diagnostic gap a...
01/10/2026

When dengue NS1 antigen and antibody tests come back negative during the acute phase, clinicians face a diagnostic gap at the moment it matters most. This case report followed a 21-year-old patient through secondary dengue infection, from a negative NS1 result on day 3 through seroconversion on day 11. While standard serological markers missed the window, serial complete blood counts performed on the HORIBA Yumizen H500 hematology analyzer captured the immune response in real time.

Extended white blood cell differential parameters, including immature granulocytes, immature monocytes, atypical lymphocytes, and large immature cells, tracked the activation of both innate and adaptive immune responses as the disease progressed. Inflammatory indices calculated from the same CBC data (neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio) reflected clinical deterioration and recovery in parallel with the patient's course.

These parameters are repeatable, practical, and cost-effective. In resource-limited settings where advanced serological testing may not be readily available, they offer a way to monitor disease progression using equipment already present in the laboratory.

🔗Read the full case report: https://eu1.hubs.ly/H0yLy1g0

Every story is unique and every journey matters. HORIBA joins the global effort to raise awareness of breast cancer. Thr...
01/10/2026

Every story is unique and every journey matters. HORIBA joins the global effort to raise awareness of breast cancer. Throughout October, we highlight the importance of early detection and stand in support of all those affected by the disease. 🩷Take care of yourself. Get screened.

Complete Blood Count (CBC) remains one of the most frequently ordered laboratory tests, yet valuable inflammatory biomar...
29/09/2026

Complete Blood Count (CBC) remains one of the most frequently ordered laboratory tests, yet valuable inflammatory biomarkers such as the Neutrophil-to-Lymphocyte Ratio (NLR) and Granulocyte-to-Lymphocyte Ratio (GLR) are often underutilized.

This workshop will explore the biological significance of these hematological ratios and how, when combined with C-reactive Protein (CRP), they can provide additional insights into immune response, inflammation, and disease severity.

Participants will discover how these biomarkers can support clinical decision-making, risk stratification, and the management of infectious and inflammatory conditions. The workshop will also examine the role of NLR, GLR, and CRP in disease severity assessment and explore how factors such as age and comorbidities can influence biomarker interpretation.

🔗Sign up here: https://eu1.hubs.ly/H0yrs0h0

New to newsletter? Start anytime.In each issue, we will delve into the fascinating world of blood and its disorders. W...
28/09/2026

New to newsletter? Start anytime.

In each issue, we will delve into the fascinating world of blood and its disorders. We will focus on blood morphology, bringing you case studies & slide reviews, hemostasis, technologies, and clinical advancements in the field of hematology.

📌 Explore back issues (case studies, morphology, hemostasis, clinical advances): https://eu1.hubs.ly/H0yFBvx0
📌 Subscribe to receive the next issue (November): https://eu1.hubs.ly/H0yFBCL0

Adresse

398 Rue Du Caducée
Grabels
34790

Heures d'ouverture

Lundi 09:00 - 18:00
Mardi 09:00 - 18:00
Mercredi 09:00 - 18:00
Jeudi 09:00 - 18:00
Vendredi 09:00 - 18:00

Téléphone

+33467141516

Site Web

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Horiba for Healthcare publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Raccourcis

Partager